Robert James Wills - Feb 23, 2024 Form 4 Insider Report for Oncternal Therapeutics, Inc. (ONCT)

Role: Director
Signature: /s/Chase C. Leavitt, Attorney-in-fact
Stock symbol: ONCT
Transactions as of: Feb 23, 2024
Transactions value $: -$8,859
Form type: 4
Date filed: 2/27/2024, 05:02 PM
Previous filing: Jan 26, 2024
Next filing: Mar 22, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ONCT	Common Stock	Sale	-$8.86K	-980	-100%	$9.04	0	Feb 23, 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares of common stock were sold directly to another director of the Issuer, David F. Hale, and an affiliated entity of Mr. Hale in a private sale. The price per share was based on the closing price of the Issuer's common stock on February 23, 2024.

Remarks:

The number of shares of common stock in this form have been adjusted to reflect the Issuer's 1-for-20 reverse stock split effective as of January 8, 2024.